Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation.
Galimberti S, Benedetti E, Morabito F, Papineschi F, Callea V, Fazzi R, Stelitano C, Andreazzoli F, Guerrini F, Ciabatti E, Martino M, Nobile F, Iacopino P, Petrini M.
Galimberti S, et al.
Leuk Res. 2005 Aug;29(8):961-6. doi: 10.1016/j.leukres.2005.01.017.
Leuk Res. 2005.
PMID: 15978948
Clinical Trial.